Regulatory officials have not found a direct link of illnesses to the facility, different strains of the organism Cronobacter sakazakii were found in the facility.
Company Press Release
https://abbott.mediaroom.com/2022-05-16-Abbott-Enters-into-Consent-Decree-with-U-S-Food-and-Drug-Administration-for-its-Sturgis,-Mich-,-Plant-Agreement-Creates-Pathway-to-Reopen-Facility
ABBOTT ENTERS INTO CONSENT DECREE WITH U.S. FOOD AND DRUG ADMINISTRATION FOR ITS STURGIS, MICH., PLANT; AGREEMENT CREATES PATHWAY TO REOPEN FACILITY
- After FDA approval, Abbott could restart the site within two weeks; from the time of restart it would take six to eight weeks before product is available on shelves
- Abbott will continue to import formula from FDA-registered facility in Ireland to help alleviate near-term supply shortage
- CDC concluded its investigation with no findings of a link between Abbott formulas and infant illnesses